Literature DB >> 8978380

Do pANCA define a clinical subgroup in patients with Crohn's disease?

N Jamar-Leclerc, D Reumaux, P Duthilleul, J F Colombel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 8978380     DOI： 10.1016/s0016-5085(97)70255-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  4 in total

Review 1.  Diagnostic methodologies: serology, endoscopy, and radiology.

Authors:  T Dassopoulos
Journal:  Curr Gastroenterol Rep       Date:  2001-12

Review 2.  Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?

Authors:  C Roozendaal; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

3.  Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.

Authors:  J F Quinton; B Sendid; D Reumaux; P Duthilleul; A Cortot; B Grandbastien; G Charrier; S R Targan; J F Colombel; D Poulain
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

4.  Cutaneous Vasculitis, Interstitial Pneumonia with Crazy-Paving Appearance, and Positive pANCA in a Patient with Severe Crohn's Disease.

Authors:  Guang-Liang Chen; Juan Wang; Bao-Zhen Li; Li-Mei Li; Han-You Mo; Shuang Ye
Journal:  Case Rep Gastrointest Med       Date:  2014-08-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.